Effects of Osteoporosis Medication Use on Reprocedure Rates Following Vertebral Augmentation: A Nationwide Cohort Study
These findings highlight the potential of osteoporosis medication use and prescription duration as predictive factors for reprocedure rates after VA. Although patients with more severe osteoporosis require longer treatment, adherence to therapy may help reduce the risk of additional interventions over time.
Authors
- Hak‐Sun Kim (ORCID: https://orcid.org/0000-0002-8330-4688)
- Namhoo Kim (ORCID: https://orcid.org/0000-0002-0849-4450)
- Si-Young Park (ORCID: https://orcid.org/0000-0002-1216-901X)
- Seong-Hwan Moon (ORCID: https://orcid.org/0000-0002-5165-1159)
- Kyung‐Soo Suk (ORCID: https://orcid.org/0000-0003-0633-2658)
- Sub-Ri Park (ORCID: https://orcid.org/0000-0001-8869-9810)
- Byung Ho Lee (ORCID: https://orcid.org/0000-0001-7235-4981)
- Minae Park (ORCID: https://orcid.org/0000-0003-3703-4514)
- Ji-Won Kwon (ORCID: https://orcid.org/0000-0003-4880-5310)
- Jae‐Won Shin (ORCID: https://orcid.org/0000-0002-6656-6336)
Institutions
- Yonsei University (KR)
- Hanmi Pharmaceutical (South Korea) (KR)
Publication Details
- Journal
- Clinics in Orthopedic Surgery
- Published
- 2025-01-01
- DOI
- https://doi.org/10.4055/cios25064
- Primary Topic
- Spinal Fractures and Fixation Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00